Laboratorios Farmaceuticos Rovi, S.A. Share Price OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.86 USD | -27.31% |
|
-.--% | - |
| 11:53am | Spanish stocks - Factors to watch on July 23 | RE |
| 13/05 | Spanish stocks - Factors to watch on May 13 | RE |
| Market Cap | 287.46Cr 328.08Cr 266.86Cr 245.22Cr 462.09Cr 32TCr 468.89Cr 3.18TCr 1.24TCr 15TCr 1.23TCr 1.21TCr 54TCr | P/E 2026 * |
21.7x | P/E 2027 * | 16.5x |
|---|---|---|---|---|---|
| Enterprise Value | 285.77Cr 326.15Cr 265.3Cr 243.78Cr 459.37Cr 31TCr 466.13Cr 3.16TCr 1.24TCr 15TCr 1.22TCr 1.2TCr 53TCr | EV / Sales 2026 * |
3.71x | EV / Sales 2027 * | 3.13x |
| Free-Float |
31.63% | Yield 2026 * |
1.73% | Yield 2027 * | 1.99% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 11:53am | Spanish stocks - Factors to watch on July 23 | RE |
| 25/02 | Spanish stocks - Factors to watch on Feb 25 | RE |
| 06/11 | Spanish stocks - Factors to watch on Nov 6 | RE |
| 05/25/05 | Spanish stocks - Factors to watch on March 5 | RE |
| 1 day | -27.31% |
| 3 years | 50.88 |  | 90.61 |
| 5 years | 0.03 | | 90.61 |
| 10 years | 0.03 | | 90.61 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -27.31% | -.--% | - | - | 328.08Cr | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,03700Cr | |
| +2.00% | +3.49% | +52.22% | +50.20% | 62TCr | |
| -1.09% | +3.76% | +35.37% | +76.22% | 45TCr | |
| -0.42% | +0.67% | +30.81% | +21.05% | 33TCr | |
| -0.16% | +2.74% | +36.02% | +37.33% | 29TCr | |
| +1.68% | +1.08% | +22.70% | +17.94% | 26TCr | |
| -1.40% | -3.34% | -24.63% | -42.39% | 22TCr | |
| -0.05% | +2.16% | +19.75% | +55.89% | 20TCr | |
| +0.05% | -1.03% | +18.31% | +61.63% | 16TCr | |
| Average | -2.98% | +1.12% | +26.70% | +47.73% | 39.53TCr | |
| Weighted average by Cap. | -0.49% | +1.47% | +35.90% | +72.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 88Cr 72Cr 66Cr 123.81Cr 8.48TCr 125.63Cr 851.81Cr 333.39Cr 4.15TCr 329.98Cr 322.87Cr 14TCr | 89Cr 101.6Cr 83Cr 76Cr 143.1Cr 9.8TCr 145.2Cr 984.5Cr 385.33Cr 4.8TCr 381.39Cr 373.17Cr 17TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 21Cr 1.45TCr 21Cr 145.19Cr 57Cr 707.45Cr 56Cr 55Cr 2.44TCr | 17Cr 20Cr 16Cr 15Cr 28Cr 1.92TCr 28Cr 192.57Cr 75Cr 938.33Cr 75Cr 73Cr 3.24TCr |
| Net Debt | -1.69Cr -1.93Cr -1.57Cr -1.44Cr -2.72Cr -186.01Cr -2.76Cr -19Cr -7.31Cr -91Cr -7.24Cr -7.08Cr -314.42Cr | -8.48Cr -9.67Cr -7.87Cr -7.23Cr -14Cr -933.4Cr -14Cr -94Cr -37Cr -456.72Cr -36Cr -36Cr -1.58TCr |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
- LABFF Stock
Select your edition
All financial news and data tailored to specific country editions
